The University of Wisconsin Clinical Cancer Center is a multidisciplinary, interdepartmental organization that facilitates high quality clinical and laboratory research training and cancer care. The Center Faculty, utilizing Center space and facilities, excels in laboratory and clinical research exploring cancer problems. Through its investigation of human cancer, it serves residents of Wisconsin and adjoining areas of Iowa and Illinois by providing optimal cancer care and innovative clinical trials. The Center offers unique opportunities to train cancer specialists in laboratory, clinical and statistical disciplines. Its outreach programs involve other cancer care and research institutions in the state as well as the public and professionals in the area. The Cancer Center Sup;port Grant to the UW Clinical Cancer Center aids in progressing towards the long term goal, reduction of the incidence, mortality and morbidity of human cancer. The broad objectives of the center are: 1. To undertake innovative laboratory and clinical research probing biologic problems in cancer. 2. To facilitate clinical applications of findings from research. 3. To improve cancer care through clinical trials. 4. To train specialists in cancer related fields. 5. To educate students, professionals and the public in Wisconsin about cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014520-19
Application #
3101432
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1976-01-01
Project End
1993-03-31
Budget Start
1991-04-01
Budget End
1992-03-31
Support Year
19
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Bednarz, Bryan; Grudzinski, Joseph; Marsh, Ian et al. (2018) Murine-specific Internal Dosimetry for Preclinical Investigations of Imaging and Therapeutic Agents. Health Phys 114:450-459
Romero-Masters, James C; Ohashi, Makoto; Djavadian, Reza et al. (2018) An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. PLoS Pathog 14:e1007221
Xu, Cheng; Chen, Feng; Valdovinos, Hector F et al. (2018) Bacteria-like mesoporous silica-coated gold nanorods for positron emission tomography and photoacoustic imaging-guided chemo-photothermal combined therapy. Biomaterials 165:56-65
Wargowski, Ellen; Johnson, Laura E; Eickhoff, Jens C et al. (2018) Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine. J Immunother Cancer 6:21
Shea, Michael P; O'Leary, Kathleen A; Fakhraldeen, Saja A et al. (2018) Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ER?+ Mammary Carcinomas. Cancer Res 78:1672-1684
Schrager, Sarina; Burnside, Elizabeth (2018) Breast Cancer Screening in Primary Care: A Call for Development and Validation of Patient-Oriented Shared Decision-Making Tools. J Womens Health (Larchmt) :
van den Broek, Jeroen J; van Ravesteyn, Nicolien T; Mandelblatt, Jeanne S et al. (2018) Comparing CISNET Breast Cancer Incidence and Mortality Predictions to Observed Clinical Trial Results of Mammography Screening from Ages 40 to 49. Med Decis Making 38:140S-150S
Lu, Zhanping; Hong, Courtney C; Kong, Guangyao et al. (2018) Polycomb Group Protein YY1 Is an Essential Regulator of Hematopoietic Stem Cell Quiescence. Cell Rep 22:1545-1559
Yu, Deyang; Yang, Shany E; Miller, Blake R et al. (2018) Short-term methionine deprivation improves metabolic health via sexually dimorphic, mTORC1-independent mechanisms. FASEB J 32:3471-3482
Carroll, Molly J; Fogg, Kaitlin C; Patel, Harin A et al. (2018) Alternatively-Activated Macrophages Upregulate Mesothelial Expression of P-Selectin to Enhance Adhesion of Ovarian Cancer Cells. Cancer Res 78:3560-3573

Showing the most recent 10 out of 1528 publications